COVID-19 Boost As Pharma ROI Hits Heights Not Seen For Seven Years, Finds Deloitte

Close-up Of White Increasing Staircase Arrow On Wooden Background
Forecasted Return On Investment Leapt To 7%, But It Is Unclear How Long The Pandemic's Effects Will Last • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip